BANK OF AMERICA CORP /DE/

Bank

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 70858 CHARLOTTE, NC

Position in INO

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$56,857

-$57,609 QoQ

Shares Held

32,677

-50.3% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. INO ranks #333 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,878,183	$1,285,223,834
2	REGN	Regeneron Pharmaceuticals, Inc.	1,189,584	$919,120,177
3	ALNY	Alnylam Pharmaceuticals, Inc.	966,912	$319,922,169
4	ARGX	Argenx SE	400,117	$292,185,437
5	INSM	INSMED Inc	1,502,281	$245,652,986
6	CYTK	Cytokinetics Inc	3,125,436	$205,997,485
7	JAZZ	Jazz Pharmaceuticals plc	1,014,800	$191,847,936
8	HALO	Halozyme Therapeutics, Inc.	2,913,109	$188,274,232

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$56,857	32,677	-50.3%	Shares	Defined	2026-05-18
2025-12-31	$114,466	65,786	-89.7%	Shares	Defined	2026-02-17
2025-09-30	$1,488,381	636,061	-49.9%	Shares	Defined	2026-02-03
2025-06-30	$2,592,036	1,270,607	-2.6%	Shares	Defined	2025-08-14
2025-03-31	$2,127,127	1,304,987	+103.6%	Shares	Defined	2025-05-15
2024-12-31	$1,173,004	640,987	+1035.2%	Shares	Defined	2025-02-14
2024-09-30	$326,372	56,466	+47.2%	Shares	Defined	2024-11-14
2024-06-30	$309,922	38,357	+2.1%	Shares	Defined	2024-08-14
2024-03-31	$521,289	37,557	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.